Please Wait...

Top-10 Biotech Uses Bioclinica Solutions to Automate and Simplify Their Payment Processes

Situation

This biotech originally managed the financial aspects of their insourced clinical trials through a homegrown investigator payment system (IPS) faced with limitations. The current system was not scalable; much of their payments tracking had to be done manually via spreadsheets, a time-consuming and often error-prone process, and there were multiple touchpoints the biotech had to go through before payments could be implemented, which overcomplicated the payments process. Additionally, the company outsourced some of its studies to CROs, which created an even greater challenge with managing payments since each of their CROs used their own internal processes that were manual and error-prone. Finally, their system did not provide the biotech with a historical view of payments that they could analyze in order to inform future budgeting and contract decisions. The biotech needed a new enterprise solution that would bring automation, simplicity, transparency and ease of use to their payments system for all current and future global studies.

Solution

The biotech researched several potential financial management solutions before coming to a decision. While other options were flashy on the surface, the biotech decided on ClinPay due to its core functionality and the depth of the system. ClinPay is part of a suite of products designed to automate the entire financial lifecycle of global clinical trials, including contract term translation, contract management, payments, accounting and reporting functionality.

In addition to ClinPay's functionality, accuracy, automation and simplicity, the biotech cited their confidence in the core Bioclinica team's expertise as a major factor in their decision.

Seamless Integrations

Bioclinica has built a complex system integration with the biotech. To streamline the complicated processes the biotech had previously used for payments, Bioclinica was able to create a single sign-on (SSO) option for ClinPay that integrated with the biotech's current portal.

The biotech is pushing a significant amount of study data from their data warehouse through Bioclinica's API, ClinConnect, to ClinPay, which allows for greater efficiencies in study setup and data access. Bioclinica also built an interface with the biotech's External Accounts Payable (EAP) system to allow for the passage of both payment and settlement information via ClinConnect. 

Additionally, the biotech requested a more simplified interface for executives who wanted a high-level overview of the data within ClinPay. Bioclinica was able to build this casual interface, which the biotech has since requested to use in other implementations as well.

Impact

While previously the biotech had CROs manage the payments for their outsourced studies, ClinPay will allow the biotech to take all of their payments back in house. Once implementation is complete, more than 30 global studies will be managed in ClinPay.

The biotech has found ClinPay's ability to show a historical view of payments, allowing for easier data analysis, to be extremely beneficial to their goals of improving efficiency in their trials. This historical view will inform how they budget and negotiate contracts in the future. Additionally, the biotech will be able to look at their entire study portfolio in one system and see reports for specific sites, which they cite as valuable. Now that the biotech has all their data in one place, they are looking to do more data analytics with ClinPay focusing on performance and costs in order to make their trials more efficient.

The biotech is planning to expand their use of Bioclinica's solutions even further to other areas of the business. With ClinPay, the biotech will be able to achieve simplicity and accuracy with their payments process as well as a better view into payments data that allows for analyses to inform future financial planning.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (2 days ago)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen